Physician profile
Amy N De La Garza
NPI 1013237593
$7,887.09
in general payments reported to CMS, 2019-2025
6 companies · $6,110 in 2025
The $6,110 reported for 2025 was more than what 96% of Addiction Medicine (Family Medicine) providers received nationally (typical 2025 total: $143).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $15.41 · 2020: $67.89 · 2022: $87.97 · 2024: $1,606 · 2025: $6,110.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Honoraria: $7,000 · Food and Beverage: $364 · Travel and Lodging: $352.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Honoraria | $7,000.00 |
| Food and Beverage | $363.96 |
| Travel and Lodging | $351.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Braeburn INC. | $7,715.82 | 2024-2025 | Brixadi |
| Alfasigma USA, INC. | $67.89 | 2020 | |
| Abbvie INC. | $58.17 | 2022 | |
| Otsuka America Pharmaceutical, INC. | $17.69 | 2022 | |
| Gilead Sciences, INC. | $15.41 | 2019 | |
| Bausch Health US, LLC | $12.11 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy De La Garza listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.